Your browser doesn't support javascript.
loading
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.
Macauda, Angelica; Piredda, Chiara; Clay-Gilmour, Alyssa I; Sainz, Juan; Buda, Gabriele; Markiewicz, Miroslaw; Barington, Torben; Ziv, Elad; Hildebrandt, Michelle A T; Belachew, Alem A; Varkonyi, Judit; Prejzner, Witold; Druzd-Sitek, Agnieszka; Spinelli, John; Andersen, Niels Frost; Hofmann, Jonathan N; Dudzinski, Marek; Martinez-Lopez, Joaquin; Iskierka-Jazdzewska, Elzbieta; Milne, Roger L; Mazur, Grzegorz; Giles, Graham G; Ebbesen, Lene Hyldahl; Rymko, Marcin; Jamroziak, Krzysztof; Subocz, Edyta; Reis, Rui Manuel; Garcia-Sanz, Ramon; Suska, Anna; Haastrup, Eva Kannik; Zawirska, Daria; Grzasko, Norbert; Vangsted, Annette Juul; Dumontet, Charles; Kruszewski, Marcin; Dutka, Magdalena; Camp, Nicola J; Waller, Rosalie G; Tomczak, Waldemar; Pelosini, Matteo; Razny, Malgorzata; Marques, Herlander; Abildgaard, Niels; Watek, Marzena; Jurczyszyn, Artur; Brown, Elizabeth E; Berndt, Sonja; Butrym, Aleksandra; Vachon, Celine M; Norman, Aaron D.
Afiliação
  • Macauda A; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Piredda C; Department of Biology, University of Pisa, Pisa, Italy.
  • Clay-Gilmour AI; Department of Biology, University of Pisa, Pisa, Italy.
  • Sainz J; Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.
  • Buda G; Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain.
  • Markiewicz M; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Barington T; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Ziv E; Department of Hematology and Bone Marrow Transplantation, SPSKM Hospital, Katowice, Poland.
  • Hildebrandt MAT; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
  • Belachew AA; Department of Medicine, Division of General Internal Medicine, Institute for Human Genetics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Varkonyi J; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Prejzner W; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Druzd-Sitek A; Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Spinelli J; Department of Hematology and Transplantation, Medical University of Gdansk, Gdansk, Poland.
  • Andersen NF; Department of Lymphoid Malignacies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Hofmann JN; Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Dudzinski M; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Martinez-Lopez J; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Iskierka-Jazdzewska E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Milne RL; Department of Hematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland.
  • Mazur G; Complutense University, CNIO, CIBERONC, Hospital 12 de Octubre, Madrid, Spain.
  • Giles GG; Department of Haematology, Copernicus Memorial Hospital, Lodz, Poland.
  • Ebbesen LH; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Rymko M; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Jamroziak K; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Subocz E; Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland.
  • Reis RM; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Garcia-Sanz R; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Suska A; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Haastrup EK; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Zawirska D; Department of Hematology, N. Copernicus Town Hospital, Torun, Poland.
  • Grzasko N; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Vangsted AJ; Department of Haematology, Military Institute of Medicine, Warsaw, Poland.
  • Dumontet C; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
  • Kruszewski M; Molecular Oncology Research Center, Barretos, São Paulo, Brazil.
  • Dutka M; Department of Hematology, University Hospital of Salamanca, IBSAL, Salamanca, Spain.
  • Camp NJ; Department of Hematology, Jagiellonian University Medical College, Cracow, Poland.
  • Waller RG; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Tomczak W; Department of Hematology, University Hospital of Cracow, Cracow, Poland.
  • Pelosini M; Department of Experimental Hematooncolog, Medical University of Lublin, Lublin, Poland.
  • Razny M; Department of Hematology, St. John's Cancer Center, Lublin, Poland.
  • Marques H; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Abildgaard N; Cancer Research Center of Lyon/Hospices Civils de Lyon, Lyon, France.
  • Watek M; Department of Hematology, University Hospital Bydgoszcz, Bydgoszcz, Poland.
  • Jurczyszyn A; Department of Hematology and Transplantation, Medical University of Gdansk, Gdansk, Poland.
  • Brown EE; University of Utah, Salt Lake City, Utah, USA.
  • Berndt S; University of Utah, Salt Lake City, Utah, USA.
  • Butrym A; Medical University of Lublin, Lublin, Poland.
  • Vachon CM; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
  • Norman AD; Department of Hematology, Rydygier Specialistic Hospital, Cracow, Poland.
Int J Cancer ; 149(2): 327-336, 2021 07 15.
Article em En | MEDLINE | ID: mdl-33675538
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apirase / Proteínas de Ligação a RNA / Perfilação da Expressão Gênica / Polimorfismo de Nucleotídeo Único / Proteínas Mitocondriais / Locos de Características Quantitativas / Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apirase / Proteínas de Ligação a RNA / Perfilação da Expressão Gênica / Polimorfismo de Nucleotídeo Único / Proteínas Mitocondriais / Locos de Características Quantitativas / Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha